ý | No fee required. |
(1) | Title of each class of securities to which transaction applies: |
(2) | Aggregate number of securities to which transaction applies: |
(3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0‑11 (Set forth the amount on which the filing fee is calculated and state how it was determined): |
(4) | Proposed maximum aggregate value of transaction: |
(5) | Total fee paid: |
¨ | Fee paid previously with preliminary materials. |
¨ | Check box if any part of the fee is offset as provided by Exchange Act Rule 0‑11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
(1) | Amount Previously Paid: |
(2) | Form, Schedule or Registration Statement No.: |
(3) | Filing Party: |
(4) | Date Filed: |
• | to elect two Class II members of the Board of Directors to serve until the 2018 annual meeting of stockholders; |
• | to ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2015; |
• | to approve on an advisory basis the compensation awarded to our named executive officers in 2014; and |
• | to transact any other business that is properly brought before the meeting or any adjournment or postponement thereof. |
By Order of the Board of Directors, | |
Reston, Virginia | |
June 8, 2015 | /s/ Christiana L. Lin |
Christiana L. Lin | |
General Counsel and Secretary |
Page | |
Important Notice Regarding the Availability of Proxy Materials for the Stockholder Meeting to be held on July 21, 2015 | 3 |
Questions and Answers About the 2015 Annual Meeting and Procedural Matters | 3 |
Directors, Director Nominees, Executive Officers and Corporate Governance | 9 |
Directors, Director Nominees and Executive Officers | 9 |
Board Structure | 11 |
Standing Committees of the Board of Directors | 11 |
Risk Management | 12 |
Board of Directors and Committee Meeting Attendance | 13 |
Annual Meeting Attendance | 13 |
Director Nomination Process and Qualifications | 13 |
Director and Director Nominee Independence | 14 |
Compensation Committee Interlocks and Insider Participation | 15 |
Code of Business Conduct and Ethics | 15 |
Corporate Governance Guidelines | 15 |
Stock Ownership Guidelines for Non-Employee Directors | 15 |
Director Compensation | 16 |
Director Compensation Policy | 16 |
2014 Director Compensation | 17 |
Executive Compensation | 18 |
Compensation Discussion and Analysis | 18 |
Compensation Committee Report | 35 |
Summary Compensation Table | 36 |
Grants of Plan-Based Awards | 38 |
Outstanding Equity Awards at Fiscal Year End | 41 |
Option Exercises and Stock Vested Table | 44 |
Potential Payments Upon Termination or Change in Control | 45 |
Certain Relationships and Related Transactions | 50 |
Policies and Procedures for Transactions with Related Persons | 50 |
Transactions and Relationships with Directors, Officers and Five Percent Stockholders | 50 |
Security Ownership of Certain Beneficial Owners and Management | 51 |
Section 16(a) Beneficial Ownership Reporting Compliance | 52 |
Principal Accounting Fees and Services | 53 |
Audit and Related Fees for Fiscal Years 2013 and 2014 | 53 |
Pre-Approval Policies and Procedures | 53 |
Audit Committee Report | 54 |
Proposals To Be Voted On | 55 |
Proposal No. 1: Election of Directors | 55 |
Proposal No. 2: Ratification of Appointment of Independent Registered Public Accounting Firm | 56 |
Proposal No. 3: Advisory Vote on Named Executive Officer Compensation | 57 |
Other Information | 58 |
Q: | Why am I receiving these proxy materials? |
A: | The Board of Directors of comScore, Inc. (the “Company,” “comScore,” “we,” “us” or “our”) has made these proxy materials available to you on the Internet, or is providing printed proxy materials to you, in connection with the solicitation of proxies for use at comScore’s 2015 Annual Meeting of Stockholders (the “2015 Annual Meeting”) to be held Tuesday, July 21, 2015, at 11:15 a.m., Eastern Time, and at any adjournment or postponement thereof, for the purpose of considering and acting upon the matters set forth in this proxy statement. These proxy materials are being made available or distributed to you on or about June 11, 2015. As a stockholder, you are invited to attend the 2015 Annual Meeting and are requested to vote on the proposals described in this proxy statement. |
Q: | Where is the 2015 Annual Meeting? |
A: | The 2015 Annual Meeting will be held at the Company's offices at 11950 Democracy Drive, Suite 600, Reston, Virginia 20190. |
Q: | Can I attend the 2015 Annual Meeting? |
A: | You are invited to attend the 2015 Annual Meeting if you were a stockholder of record or a beneficial owner as of June 5, 2015 (the “Record Date”). You should bring photo identification and your Notice of Internet Availability, a statement from your broker, or other proof of stock ownership as of the Record Date, for entrance to the 2015 Annual Meeting. The meeting will begin promptly at 11:15 a.m., Eastern Time and you should leave ample time for check-in procedures. We will not be able to accommodate guests who were not stockholders as of the Record Date at the 2015 Annual Meeting. |
Q: | Who is entitled to vote at the 2015 Annual Meeting? |
A: | You may vote your shares of comScore common stock if our records show that you owned your shares at the close of business on the Record Date. At the close of business on the Record Date, there were 40, 237,526 shares of comScore common stock outstanding and entitled to vote at the 2015 Annual Meeting. You may cast one vote for each share of common stock held by you as of the Record Date on all matters presented. As of the Record Date, holders of common stock are eligible to cast an aggregate of 40, 237,526 votes at the 2015 Annual Meeting. |
Q: | What is the difference between holding shares as a stockholder of record or as a beneficial owner? |
A: | If your shares are registered directly in your name with comScore’s transfer agent, American Stock Transfer & Trust Company, you are considered, with respect to those shares, the “stockholder of record,” and the Notice of Internet Availability has been sent directly to you by comScore. As the stockholder of record, you have the right to grant your voting proxy directly to comScore or to a third party, or to vote in person at the 2015 Annual Meeting. If your shares are held by a brokerage account or by a bank or another nominee, you are considered the “beneficial owner” of shares held in “street name,” and the Notice of Internet Availability has been forwarded to you by your broker, trustee or nominee who is considered, with respect to those shares, the stockholder of record. As a beneficial owner, you have the right to direct your broker, trustee or nominee how to vote your shares. Please refer to the voting instruction card provided by your broker, trustee or nominee. You are also invited to attend the 2015Annual Meeting. However, because a beneficial owner is not the stockholder of record, you may not vote these shares in person at the 2015 Annual Meeting unless you obtain a “legal proxy” from the broker, trustee or nominee that holds your shares, giving you the right to vote the shares at the 2015 Annual Meeting. |
Q: | How can I vote my shares in person at the 2015 Annual Meeting? |
A: | Shares held in your name as the stockholder of record may be voted in person at the 2015 Annual Meeting. Shares held beneficially in street name may be voted in person at the 2015 Annual Meeting only if you obtain a “legal proxy” from the broker, trustee or nominee that holds your shares giving you the right to vote the shares. Even if you plan to attend the 2015 Annual Meeting, we recommend that you also submit your vote as instructed on the Notice of Internet Availability and below, so that your vote will be counted even if you later decide not to attend the 2015 Annual Meeting. |
Q: | How can I vote my shares without attending the 2015 Annual Meeting? |
A: | Whether you hold shares directly as the stockholder of record or beneficially in street name, you may direct how your shares are voted without attending the 2015 Annual Meeting. If you are a stockholder of record, you may vote by submitting a proxy. If you hold shares beneficially in street name, you may vote by submitting voting instructions to your broker, trustee or nominee. For instructions on how to vote, please refer to the instructions below and those included on the Notice of Internet Availability or, for shares held beneficially in street name, the voting instructions provided to you by your broker, trustee or nominee. By Internet - Stockholders of record of comScore common stock with Internet access may submit proxies by following the “Internet” instructions on the Notice of Internet Availability until 11:15 am, Eastern Time on July 21, 2015. If you are a beneficial owner of comScore common stock held in street name, please check the voting instructions provided by your broker, trustee or nominee for Internet voting availability. By mail - Stockholders of record of comScore common stock may request a paper proxy card from comScore by following the procedures outlined in the Notice of Internet Availability. If you elect to vote by mail, please indicate your vote by completing, signing and dating the proxy card where indicated and by returning it in the prepaid envelope that will be included with the proxy card. Proxy cards submitted by mail must be received by the time of the meeting in order for your shares to be voted. comScore stockholders who hold shares beneficially in street name may vote by mail by completing, signing and dating the voting instructions provided by their brokers, trustees or nominees and mailing them in the accompanying pre-addressed envelopes. |
Q: | How many shares must be present or represented to conduct business at the 2015 Annual Meeting? |
A: | The presence of the holders of a majority of the shares entitled to vote at the 2015 Annual Meeting is necessary to constitute a quorum at the 2015 Annual Meeting. Such stockholders are counted as present at the meeting if (1) they are present in person at the 2015 Annual Meeting or (2) have properly submitted a proxy. Under the General Corporation Law of the State of Delaware, abstentions and broker non-votes are counted as present and entitled to vote and are, therefore, included for the purposes of determining whether a quorum is present at the 2015 Annual Meeting. A “broker non-vote” occurs when a nominee holding shares for a beneficial owner does not vote on a particular proposal because the nominee does not have discretionary voting power with respect to that item and has not received voting instructions from the beneficial owner. |
Q: | What proposals will be voted on at the 2015 Annual Meeting? |
A: | The proposals scheduled to be voted on at the 2015 Annual Meeting are: |
(1) The election of the two Class II directors listed in this proxy statement to serve until the 2018 annual meeting of stockholders; (2) The ratification of the appointment of Ernst & Young LLP as comScore’s independent registered public accounting firm for the fiscal year ending December 31, 2015; and (3) The approval on an advisory basis of the compensation awarded to our named executive officers in 2014. | |
Q: | What is the voting requirement to approve each of the proposals? |
A: | Proposal | Vote Required | Broker Discretionary Voting Allowed |
Proposal One - Election of two Class II directors | Plurality of Votes Cast | No | |
Proposal Two - Ratification of the appointment of independent registered public accounting firm | Majority of the Shares Entitled to Vote and Present in Person or Represented by Proxy | Yes | |
Proposal Three - Approval on an advisory basis of 2014 named executive officer compensation | Majority of the Shares Entitled to Vote and Present in Person or Represented by Proxy | No |
Q: | How are votes counted? |
A: | You may vote “FOR” or “WITHHOLD” on each of the nominees for election as director (Proposal One). The two nominees for director receiving the highest number of affirmative votes will be elected as directors. You may vote “FOR,” “AGAINST” or “ABSTAIN” on the proposals to ratify the appointment of Ernst & Young LLP as comScore’s independent registered public accounting firm (Proposal Two) and to approve, by non-binding vote, executive compensation (Proposal Three). Abstentions are deemed to be votes cast and have the same effect as a vote against these proposals. All shares entitled to vote and represented by properly executed proxies received prior to the 2015 Annual Meeting (and not revoked) will be voted at the 2015 Annual Meeting in accordance with the instructions indicated. |
Q: | What if I do not specify how my shares are to be voted? |
A: | You may vote “FOR” or “WITHHOLD” on each of the nominees for election as director (Proposal One). The two nominees for director receiving the highest number of affirmative votes will be elected as directors. Therefore, abstentions will not affect the outcome of the election. If you are a stockholder of record and you submit a proxy, but you do not provide voting instructions, your shares will be voted as recommended by the Board of Directors. If you are a beneficial owner and you do not provide the broker or other nominee that holds your shares with voting instructions, the broker or other nominee will determine if it has the discretionary authority to vote on the particular matter. Under applicable regulations, brokers and other nominees have the discretion to vote on routine matters such as Proposal Two but do not have discretion to vote on Proposal Three. Therefore, if you do not provide voting instructions to your broker or other nominee, your broker or other nominee may only vote your shares on Proposal Two and any other routine matters properly presented for a vote at the 2015 Annual Meeting. |
Q: | What is the effect of a broker non-vote? |
A: | Brokers or other nominees who hold shares of comScore’s common stock for a beneficial owner have the discretion to vote on routine proposals when they have not received voting instructions from the beneficial owner at least ten days prior to the 2015 Annual Meeting. A broker non-vote occurs when a broker or other nominee does not receive voting instructions from the beneficial owner and does not have the discretion to direct the voting of the shares. Broker non-votes will be counted for purposes of calculating whether a quorum is present at the 2015 Annual Meeting, but will not be counted for purposes of determining the number of votes present in person or represented by proxy and entitled to vote with respect to a particular proposal. Thus, a broker non-vote will not impact our ability to obtain a quorum and will not otherwise affect the outcome of the vote on a proposal that requires a plurality of votes cast (Proposal One) or the approval of a majority of the votes present in person or represented by proxy and entitled to vote (Proposal Three). |
Q: | What is the effect of not casting a vote at the 2015 Annual Meeting? |
A: | If you are the stockholder of record of your shares and you do not vote by proxy card, via the Internet or in person at the 2015 Annual Meeting, your shares will not be voted at the 2015 Annual Meeting. If you are a beneficial owner of shares held in street name, it is critical that you provide voting instructions if you want it to count in the election of directors (Proposal One) or the non-binding vote on executive compensation (Proposal Three). In the past, if you held your shares in street name and you did not indicate how you wanted your shares voted in the election of directors, your bank or broker was allowed to vote those shares on your behalf in the election of directors as they felt appropriate. Under applicable regulations, your bank or broker does not have the ability to vote your uninstructed shares in the election of directors on a discretionary basis or to vote your uninstructed shares in non-binding proposals related to executive compensation. Thus, if you hold your shares in street name and you do not instruct your bank or broker how to vote in these matters, no votes will be cast on your behalf. Your bank or broker will, however, continue to have discretion to vote any uninstructed shares on the ratification of the appointment of comScore’s independent registered public accounting firm (Proposal Two). |
Q: | How does the Board of Directors recommend that I vote? |
A: | The Board of Directors recommends that you vote your shares: |
“FOR” the two nominees for election as directors (Proposal One); “FOR” the ratification of the appointment of Ernst & Young LLP as comScore’s independent registered public accounting firm for the fiscal year ending December 31, 2015 (Proposal Two); and “FOR” the approval, by non-binding vote, of the 2014 compensation of the named executive officers(Proposal Three). | |
Q: | What happens if additional matters are presented at the 2015 Annual Meeting? |
A. | If any other matters are properly presented for consideration at the 2015 Annual Meeting, including, among other things, consideration of a motion to adjourn the 2015 Annual Meeting to another time or place (including, without limitation, for the purpose of soliciting additional proxies), the persons named as proxy holders, Magid M. Abraham and Serge Matta, or either of them, will have discretion to vote on those matters in accordance with their best judgment. comScore does not currently anticipate that any other matters will be raised at the 2015 Annual Meeting. |
Q: | Can I change my vote? |
A: | Subject to any rules your broker, trustee or nominee may have, you may change your proxy instructions at any time before your proxy is voted at the 2015 Annual Meeting. If you are the stockholder of record, you may change your vote (1) by granting a new proxy bearing a later date (which automatically revokes the earlier proxy) using any of the voting methods described above (and until the applicable deadline for each voting method), (2) by providing a written notice of revocation to comScore’s Corporate Secretary at comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190 prior to your shares being voted, or (3) by attending the 2015 Annual Meeting and voting in person. Attendance at the meeting will not cause your previously granted proxy to be revoked unless you specifically so request. If you are a beneficial owner of shares held in street name, you may change your vote by (1) submitting new voting instructions to your broker, trustee or nominee or (2) if you have obtained a legal proxy from the broker, trustee or nominee that holds your shares giving you the right to vote your shares, by attending the 2015 Annual Meeting and voting in person. |
Q: | What happens if I decide to attend the 2015 Annual Meeting, but I have already voted or submitted a proxy card covering my shares? |
A: | Subject to any rules your broker, trustee or nominee may have, you may attend the 2015 Annual Meeting and vote in person even if you have already voted or submitted a proxy card. Any previous votes that were submitted by you will be superseded by the vote you cast at the 2015 Annual Meeting. Please be aware that attendance at the 2015 Annual Meeting will not, by itself, revoke a proxy. If a broker, trustee or nominee beneficially holds your shares in street name and you wish to attend the 2015 Annual Meeting and vote in person, you must obtain a legal proxy from the broker, trustee or nominee that holds your shares giving you the right to vote the shares. |
Q: | What should I do if I receive more than one Notice of Internet Availability or set of proxy materials? |
A: | You may receive more than one Notice of Internet Availability or set of proxy materials, including multiple copies of proxy cards or voting instruction cards. For example, if you hold your shares in more than one brokerage account, you may receive a separate Notice of Internet Availability or voting instruction card for each brokerage account in which you hold shares. If you are a stockholder of record and your shares are registered in more than one name, you will receive more than one Notice of Internet Availability or proxy card. Please complete, sign, date and return each comScore proxy card or voting instruction card that you receive to ensure that all your shares are voted. |
Q: | Who will count the votes? |
A: | comScore’s Board of Directors has designated representatives of Wilson Sonsini Goodrich & Rosati, the Company’s outside counsel, to serve as inspector of election. |
Q: | Where can I find the voting results of the 2015 Annual Meeting? |
A: | We intend to announce preliminary voting results at the 2015 Annual Meeting and will publish final results in our Current Report on Form 8-K, which will be filed with the SEC within four (4) business days following the 2015 Annual Meeting. |
Q: | Who will bear the cost of soliciting votes for the 2015 Annual Meeting? |
A: | comScore will pay the entire cost of preparing, assembling, printing, mailing and distributing these proxy materials and soliciting votes. We may reimburse brokerage firms, custodians, nominees, fiduciaries and other persons representing beneficial owners for their reasonable expenses in forwarding solicitation material to such beneficial owners. Our directors, officers and employees may also solicit proxies in person or by other means of communication. Such directors, officers and employees will not be additionally compensated but may be reimbursed for reasonable out-of-pocket expenses in connection with such solicitation. If you choose to access the proxy materials and/or vote over the Internet, you are responsible for Internet access charges you may incur. |
Q: | What is the deadline to propose actions for consideration at next year's annual meeting of stockholders or to nominate individuals to serve as directors? |
A: | You may submit proposals, including recommendations of director candidates, for consideration at future stockholder meetings. comScore’s bylaws provide for advance notice procedures to recommend a person for nomination as a director or to propose business to be considered by stockholders at a meeting. For the 2016 annual meeting of stockholders, such nominations or proposals, other than those made by or at the direction of the Board of Directors, must be submitted in writing and received by our Corporate Secretary at our offices no later than March 13, 2016, which is 90 days prior to the anniversary of the expected first mailing date of notice of availability of this proxy statement. If our 2016 annual meeting of stockholders is moved more than 30 days before or after the anniversary date of our 2015 Annual Meeting, then the deadline is the close of business on the tenth day following the day notice of the date of the meeting was mailed or made public, whichever occurs first. Such proposals also must comply with all applicable requirements of the rules and regulations of the SEC. The chairperson of the stockholder meeting may refuse to acknowledge the introduction of your proposal if it is not made in compliance with the foregoing procedures or the applicable provisions of our bylaws. If a stockholder who has notified comScore of his or her intention to present a proposal at an annual meeting does not appear to present his or her proposal at such meeting, comScore need not present the proposal for vote at such meeting. |
In addition, for a stockholder proposal to be considered for inclusion in our proxy statement for the 2016 annual meeting of stockholders, the proposal must be submitted in writing and received by our Corporate Secretary at our offices at 11950 Democracy Drive, Suite 600, Reston, Virginia 20190 no later than February 12, 2016, which is 120 days prior to the anniversary of the expected mailing date of the notice of availability of this proxy statement. A copy of the full text of the bylaw provisions discussed above may be obtained by writing to comScore’s Corporate Secretary at our principal executive offices at 11950 Democracy Drive, Suite 600, Reston, Virginia 20190 or by accessing comScore’s filings on the SEC’s website at www.sec.gov. All notices of proposals by stockholders, whether or not included in comScore’s proxy materials, should be sent to comScore’s Corporate Secretary at our principal executive offices. | |
Q: | How may I obtain a separate copy of the Notice of Internet Availability? |
A: | If you share an address with another stockholder, each stockholder may not receive a separate copy of the Notice of Internet Availability. Stockholders may request to receive separate or additional copies of the Notice of Internet Availability by writing to comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attention: Investor Relations. Stockholders who share an address and receive multiple copies of the Notice of Internet Availability can also request to receive a single copy by following the instructions above. |
Q: | How may I obtain comScore’s 2014 Form 10-K and other financial information? |
A: | Stockholders can access our 2014 Form 10-K, and other financial information on our website at www.comscore.com through the "Investor Relations" link on the "About Us" webpage or on the Securities and Exchange Commission's website at www.sec.gov. Alternatively, current and prospective investors may request a free copy of our 2014 Form 10-K, from: comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attention: Investor Relations. We also will furnish any exhibit to the 2014 Form 10-K if specifically requested upon payment of charges that approximate our cost of reproduction. |
Q: | Who can help answer my questions? |
A: | Please contact our legal department by calling 703-438-2000 or by writing to comScore, Inc., 11950 Democracy Drive, Suite 600, Reston, Virginia 20190, Attention: Legal Department. |
Name | Age | Position |
Executive Officers and Executive Directors | ||
Serge Matta | 40 | President, Chief Executive Officer and Class III Director |
Magid M. Abraham, Ph.D. | 56 | Executive Chairman of the Board of Directors and Class I Director |
Gian M. Fulgoni | 67 | Chairman Emeritus and Class III Director |
Melvin Wesley III | 43 | Chief Financial Officer |
Cameron Meierhoefer | 43 | Chief Operating Officer |
Christiana L. Lin | 45 | Executive Vice President, General Counsel and Chief Privacy Officer |
Michael A. Brown | 45 | Chief Technology Officer |
Non-Employee Directors | ||
Russell Fradin(1)(2) | 38 | Class I Director |
William J. Henderson(1)(2)(3) | 67 | Class II Director |
William Katz(1)(2) | 60 | Class I Director |
Ronald J. Korn(3) | 75 | Class II Director |
Joan M. Lewis(3) | 49 | Class III Director |
(1) | Member of Nominating and Governance Committee |
(2) | Member of Compensation Committee |
(3) | Member of Audit Committee |
• | the name, age, business address and residence address of the proposed candidate; |
• | the principal occupation or employment of the proposed candidate; |
• | the class and number of shares of our stock that the proposed candidate beneficially owns; |
• | a description of all arrangements or understandings between the stockholder making the recommendations and each director nominee and any other person or persons (naming such person or persons) pursuant to which the nominations are to be made by the stockholder; and |
• | any other information relating to such director candidate that is required to be disclosed in solicitations of proxies for elections of directors or is otherwise required pursuant to Regulation 14A under the Securities Exchange Act of 1934, as amended (including without limitation such nominee’s written consent to being named in any proxy statement as a nominee and to serve as a director if elected). |
• | a high degree of personal and professional integrity; |
• | commitment to promoting the long term interests of our stockholders; |
• | broad general business experience and acumen, which may include experience in management, finance, marketing and accounting, with particular emphasis on technology companies; |
• | adequate time to devote attention to the affairs of our company; |
• | an ability to bring balance to our Board of Directors in light of our company’s current and anticipated needs and in light of the skills and attributes of the other board members; and |
• | other attributes relevant to satisfying the requirements imposed by the SEC and NASDAQ. |
2014 | ||||||
Committee | Chairperson | Member | ||||
Audit | $ | 18,000 | $ | 10,000 | ||
Compensation | 10,000 | 5,000 | ||||
Nominating and Governance | 7,500 | 3,000 |
Name | Fees Earned or Paid in Cash ($)(1) | Stock Awards ($)(2)(3) | Total ($) |
Russell Fradin | 15,833 | 125,018 | 140,851 |
Jeffrey Ganek(4) | 40,000 | 125,018 | 165,018 |
William J. Henderson | 55,000 | 125,018 | 180,018 |
William Katz | 42,500 | 125,018 | 167,518 |
Ronald J. Korn | 48,000 | 125,018 | 173,018 |
Jarl Mohn(5) | 22,084 | - | 22,084 |
(1) | Effective October 2014, our Board of Directors amended our director compensation policy to include an annual cash retainer payable to the lead independent director. The amounts reported in this table reflect that amendment |
(2) | Represents the aggregate grant date fair value of $37.23 per share computed in accordance with FASB ASC Topic 718 of the stock awards granted to the non-employees in 2014. The assumptions used in the calculation of these award amounts are included in Note 11 to the consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2014. Each non-employee director elected at the 2014 annual meeting of stockholders received a retainer consisting of a restricted stock unit award valued at approximately $125,018, equal to 3,358 shares of the Company's common stock valued at $37.23 per share in accordance with FASB ASC Topic 718. |
(3) | At December 31, 2014, the aggregate number of shares of the Company's common stock subject to stock options exercisable and outstanding for our non-employee directors was 4,000, and the aggregate number of shares of the Company's common stock covered by unvested restricted stock units was 16,790. |
Name | Award Type | Grant Date | Number of Shares | Grant Date Fair Value ($) |
Russell Fradin | Restricted Stock Units | July 22, 2014 | 3,358 | 125,018 |
Jeffrey Ganek(1) | Restricted Stock Units | July 22, 2014 | 3,358 | 125,018 |
William J. Henderson | Restricted Stock Units | July 22, 2014 | 3,358 | 125,018 |
William Katz | Restricted Stock Units | July 22, 2014 | 3,358 | 125,018 |
Ronald J. Korn | Restricted Stock Units | July 22, 2014 | 3,358 | 125,018 |
Jarl Mohn(2) | Restricted Stock Units | July 22, 2014 | 3,358 | 125,018 |
(1) | Mr. Ganek resigned from our Board of Directors effective January 15, 2015. |
(2) | Mr. Mohn did not stand for reelection to our Board of Directors at the end of his term in July 2014. |
• | Serge Matta, President and Chief Executive Officer (our “Chief Executive Officer”); |
• | Magid Abraham, Executive Chairman of our Board of Directors (our “Executive Chairman") and former Chief Executive Officer; |
• | Gian M. Fulgoni, Chairman Emeritus and Director; |
• | Melvin Wesley III, Chief Financial Officer (our "CFO"); |
• | Cameron Meierhoefer, Chief Operating Officer; |
• | Christiana Lin, Executive Vice President, General Counsel and Chief Privacy Officer; and |
• | Kenneth J. Tarpey, former Chief Financial Officer (retired August 28, 2014). |
▪ | Our market capitalization grew by 60% in spite of a 2% decrease in our shares outstanding; and |
▪ | Our share price increased by 62% from $28.61 per share at December 31, 2013 to $46.43 per share at December 31, 2014. |
• | Significantly expanded our global footprint for our flagship suite of audience measurement products, Media Metrix (or MMX). MMX Multi-Platform, which measures desktop computers, smartphones and tablets, is now available in 10 markets and MMX Mobile is offered in 21 countries across the globe; |
• | Launched vCE 2.0, an updated version of our flagship advertising service which provides data that is faster, more granular, and which incorporates multiple data inputs to achieve significantly higher accuracy, was made available in the United States, United Kingdom, Italy, and Canada; and |
• | Acquired mDot Labs, integrating the employees as well as their unique fraud-fighting technology into our Company and our product line. |
▪ | In early 2014, we entered into strategic agreements with Google and Yahoo to integrate our real-time advertising offering into their advertising management platforms, which is critical to; and |
▪ | In late 2014, we entered into significant partnerships with Pandora to ingest demographic information about mobile consumers to improve our products and with Datalogix to incorporate their consumer segmentation data into our advertising product suite. |
• | Increased his annual base salary from $415,000 to $475,000; |
• | Increased his annual incentive target opportunity to $700,000; |
• | Increased his target performance-based long-term incentive opportunity to $700,000; |
• | Increased his annual time-based long-term incentive opportunity to $700,000; and |
• | Granted him a one-time "promotion" equity award in the form of a restricted stock unit award for 44,459 shares of our common stock as follows: |
◦ | One-half of the award, or 22,230 shares, would be earned based on our actual achievement as compared against company-level performance objectives established for 2014, and |
◦ | One-half of the award, or 22,229 shares, to vest in three equal annual installments in February 2015, 2016, and 2017, all subject to his continued service on each respective vesting date. |
• | At his request, reduced his annual base salary from $500,000 to $250,000, to be paid in the form of restricted shares of our common stock in lieu of cash; |
• | Agreed that the restricted stock unit award for 96,666 shares of our common stock originally granted to him in 2012, while he was serving as Chief Executive Officer, and which was to be subject to the achievement of company-level performance objectives established in 2014, would remain in force, with the performance objectives realigned to focus on Dr. Abraham's responsibilities in connection with the Chief Executive Officer transition, and as Executive Chairman; |
• | Agreed that the restricted stock unit award for 96,666 shares of our common stock originally granted to him in 2012, while he was serving as Chief Executive Officer, and which was to reward the overachievement of the 2014 performance objectives, would be reduced by 50% to a restricted stock unit award for 48,333 shares of our common stock, with the performance objectives realigned to focus on Dr. Abraham's responsibilities in connection with the Chief Executive Officer transition, and as Executive Chairman; and |
• | Agreed that the restricted stock award for 70,000 shares of our common stock, originally granted to him in 2012, while he was serving as Chief Executive Officer, for retention purposes would be allowed to continue vesting in accordance with its original terms, subject to Dr. Abraham's continued service through March 2015. |
• | A base salary of $320,000; |
• | A target annual incentive opportunity of $240,000, based on achievement of 2014 performance objectives; |
• | A target performance-based long-term incentive opportunity of $450,000, based on achievement of 2014 performance objectives, but with any shares earned subject to a three-year time-based vesting requirement; and |
• | Eligibility for a time-based long-term incentive in the amount of $300,000 subject to a three-year vesting requirement. |
▪ | Compensation Committee Independence - Our Board of Directors maintains a compensation committee comprised solely of independent directors who have established effective means for communicating with our stockholders regarding their executive compensation ideas and concerns. |
▪ | Compensation Committee Advisor Independence - Our Compensation Committee engages and retains its own advisors. During 2014, the Compensation Committee engaged Compensia, Inc. to assist with its responsibilities. Compensia performs no consulting or other services for the Company. |
▪ | Annual Compensation Review - Our Compensation Committee conducts an annual review of our executive compensation philosophy and strategy, including a review of the compensation peer group used for comparative purposes. |
▪ | Compensation-Related Risk Assessment - As part of the annual review of our executive compensation philosophy and strategy, we also evaluate our compensation programs, policies, and practices to ensure that they reflect an appropriate level of risk-taking but do not encourage our employees to take excessive or unnecessary risks that could have a material adverse impact on the Company. |
▪ | Emphasize Performance-based Incentive Compensation - Our Compensation Committee designs our executive compensation program to use performance-based short-term and long-term incentive compensation awards to align of the long-term interests of our executive officers with the interests of our stockholders. |
▪ | Emphasize Long-Term Equity Compensation - Our Compensation Committee uses equity awards to deliver long-term incentive compensation opportunities to our executive officers, including our named executive officers. These equity awards vest or may be earned over multi-year periods, which better serves our long-term value creation goals and retention objectives. |
▪ | Limited Executive Perquisites - We provide only modest amounts of perquisites or other personal benefits to our named executive officers which serve a sound business purpose. In addition, our named executive officers participate in our health and welfare benefit programs on the same basis as all of our employees. |
▪ | “Double-Trigger” Change in Control Arrangements - The post-employment compensation arrangements for certain of our named executive officers, including our Chief Executive Officer, our Chief Financial Officer, our Chief Operating Officer and General Counsel, are based on a “double-trigger” arrangement that provides for the receipt of payments and benefits only in the event of (i) a change in control of the Company and (ii) a qualifying termination of employment |
▪ | Reasonable Change-in-Control Arrangements - The post-employment compensation arrangements for certain of our executive officers, including our named executive officers, provide for amounts and multiples that are within reasonable market norms. |
▪ | Prohibition on Hedging and Pledging - Our executive officers, including our named executive officers, and the members of our Board of Directors are prohibited from engaging in hedging transactions with respect to our equity securities. Our executive officers, including our named executive officers, are also prohibited from pledging shares of our common stock. |
▪ | Succession Planning - Our Board of Directors reviews the risks associated with our key executive positions with our Chief Executive Officer on a periodic basis so that we identify and prepare for an adequate succession strategy and plans are in place for our most critical positions. |
▪ | Retirement Programs - Other than our Section 401(k) plan generally available to all employees, we do not offer defined benefit or contribution retirement plans or arrangements or nonqualified deferred compensation plans or arrangements for our executive officers, including our named executive officers. |
▪ | No Tax “Gross-Ups” or Payments - We do not provide any “gross-ups” or tax payments in connection with any compensation element or any excise tax “gross-up” or tax reimbursement in connection with any change in control payments or benefits. |
▪ | No Dividends - We do not pay dividends or dividend equivalents on unvested or unearned restricted stock units and performance-based restricted stock unit awards. |
▪ | No Stock Option Repricing - We do not reprice options to purchase shares of our common stock without stockholder approval. |
• | Align Stockholder Interests and Promote Achievement of Strategic Objectives. Not only should our compensation arrangements be tied to our financial performance, strong performance-based equity awards for high growth in the value of our common stock serve to align our executive officers’ interests with those of our stockholders. |
• | Promote Achievement of Financial Goals. Compensation should be dependent on the achievement of our financial goals and increasing the value of our common stock. We seek to establish financial targets that are aligned with the financial targets that we provide to our investors and stockholders in the beginning of the year. |
• | Reward Superior Performance. We believe that while total compensation for an executive should be both competitive and tied to achievement of financial goals and strategic objectives, performance that exceeds targets should be appropriately awarded. |
• | Attract and Retain Top Talent. Our compensation arrangements should be sufficient to allow us to attract, retain and motivate executive officers with the necessary skills and talent to successfully manage our business, taking into consideration a number of factors such as market analyses, experience, alternative market opportunities, and consistency with the compensation paid to other professionals within our organization. |
• | develop a culture that embodies a passion for our business and a drive to achieve and exceed established goals and objectives; |
• | provide leadership to the organization in such a way as to maximize the results of our business operations; |
• | lead us by demonstrating forward thinking in the operation, development and expansion of our business; and |
• | effectively manage organizational resources to derive the greatest value possible from each dollar invested. |
• | regularly reviews the performance of and the total compensation earned by or awarded to our Chief Executive Officer and Executive Chairman independent of input from them; |
• | examines on an annual basis the performance of our other named executive officers with assistance from our Chief Executive Officer and Executive Chairman and approves total compensation packages for them that it believes to be consistent with those generally found in the marketplace for executives in comparable positions; |
• | regularly holds executive sessions without management present; and |
• | engages a compensation consultant to review our executive compensation policies and practices and provide analysis of the competitive market for our executive officers in connection with each component of our executive officer compensation packages. |
(i) | how much we would be willing to pay to retain that named executive officer; |
(ii) | how much we would expect to pay in the marketplace to replace that named executive officer; |
(iii) | how much that named executive officer could otherwise command in the employment marketplace; |
(iv) | past performance as well as the strategic value of the executive officer's future contributions; and |
(v) | internal parity. |
Constant Contact Costar Group Dealertrack Technologies Dice Holdings Liquidity Services | LivePerson LogMeIn MicroStrategy OpenTable QuinStreet | Responsys Synchronoss Technologies Vocus Web.com Group WebMD Health |
Name | 2013 | 2014 | Percentage Change | |||||
Serge Matta | $ | 415,000 | $ | 475,000 | 14.5 | % | ||
Magid M. Abraham, Ph.D. | 500,000 | 250,000(1) | (50.0 | )% | ||||
Gian M. Fulgoni | 375,000 | 375,000(1) | 0.0 | % | ||||
Kenneth J. Tarpey (retired August 28, 2014) | 367,500 | 367,500 | 0.0 | % | ||||
Cameron Meierhoefer | 321,000 | 353,000 | 10.0 | % | ||||
Christiana Lin | 302,500 | 333,000 | 10.0 | % |
(1) | For the period from January 1, 2014 through December 31, 2014, in lieu of receiving a cash salary, each of Dr. Abraham and Mr. Fulgoni received an award of shares of our common stock with a value equal to the amount of salary foregone by each, less amounts paid to them in cash during 2014 to cover health benefits, based on the closing price of our common stock as reported on the NASDAQ Global Market at the close of trading on March 31, 2014, June 30, 2014, September 30, 2014 and December 31, 2014. The number of shares of our common stock delivered to each named executive officer was reduced by the number of shares necessary to satisfy applicable tax withholding requirements. |
Name | Target Annual Incentive Award Opportunity ($) | Maximum Annual Incentive Award Opportunity ($) | ||||
Serge Matta | $ | 700,000 | $ | 1,400,000 | ||
Gian M. Fulgoni | 375,000 | 750,000 | ||||
Kenneth J. Tarpey (retired August 28, 2014) | 275,625 | 551,250 | ||||
Cameron Meierhoefer | 264,750 | 529,500 | ||||
Christiana Lin | 249,750 | 499,500 |
Name | Corporate Performance Objective - Revenue | Corporate Performance Objective - Adjusted EBITDA | Individual Performance Objectives |
Serge Matta | 50% | 50% | N/A |
Gian M. Fulgoni | 80% | N/A | 20% |
Kenneth J. Tarpey (retired August 28, 2014) | 80% | N/A | 20% |
Cameron Meierhoefer | 50% | N/A | 50% |
Christiana Lin | N/A | N/A | 100% |
Performance Measure | Threshold Performance | Target Performance | Maximum Performance |
Revenue | $311 million | $322 million | $334 million |
Adjusted EBITDA | $57.5 million | $63.0 million | $70.5 million |
▪ | Mr. Fulgoni: assist with the Executive Chairman transition, continue investor relations work, reinforce our message among investors and analysts, and serve as a thought leader in support of our brand-building activities. |
▪ | Mr. Tarpey: improve financial infrastructure and systems, improve management of international entity structure, improve operational efficiencies in the finance and accounting teams; expand sell side analyst coverage of our Company's performance |
▪ | Mr. Wesley: learn comScore organization, products, and processes, review opportunities for improvement in finance organization and drive plans for implementing such improvements, providing strategic and practical oversight over comScore financial activities including structure, compliance, planning, forecasting and expense management, and, establishing leadership tone within the finance organization. |
▪ | Mr. Meierhoefer: re-align our product and operational organizations to improve the effectiveness of these teams, develop and deploy critical technical data collection solutions, and attain critical new product capabilities, and integrate strategic data inputs into our flagship advertising analytics products, as well as launch our international mobile products and continue the development of cross platform solutions. |
▪ | Ms. Lin: successful closure of strategic commercial and corporate deals, successful wind down of significant |
Performance Measure | Target Performance Level | Actual Performance Level | Performance as a Percentage of Target |
Revenue | $322 million | $329.2 million | 165 % |
Adjusted EBITDA | $63.0 million | $71.37 million | 200 % |
Name | Individual Performance Objectives Attainment Level |
Serge Matta | N/A |
Gian M. Fulgoni | 100% |
Melvin Wesley | 91% |
Cameron Meierhoefer | 92% |
Christiana Lin | 98% |
Name (1) | Target Annual Incentive Award Opportunity ($) | Actual Annual Incentive Award ($) | Actual Annual Incentive Award (number of shares) (2) | Actual Annual Incentive Achieved Against Target (%) | ||||||
Serge Matta | $ | 700,000 | $ | 1,287,775 | 29,629 | 184 | % | |||
Gian M. Fulgoni | 375,000 | 571,093 | 13,232 | 152 | % | |||||
Melvin Wesley III | 240,000 | 383,128 | 8,877 | 160 | % | |||||
Cameron Meierhoefer | 265,000 | 340,951 | 7,900 | 127 | % | |||||
Christiana Lin | 249,500 | 249,750 | 5,787 | 100 | % |
(1) | Mr. Tarpey did not receive an annual incentive award because he retired from the Company during 2014. |
(2) | The number of shares of our common stock received was determined based on the closing price of our common stock reported on the NASDAQ Global Select Market on February 11, 2015, which was $43.16 per share. |
Name and Principal Position | Target Annual Incentive Award Opportunity ($) | Maximum Annual Incentive Award Opportunity ($) | ||||
Serge Matta | $ | 700,000 | $ | 1,400,000 | ||
Gian M. Fulgoni | 275,000 | 500,000 | ||||
Kenneth J. Tarpey (retired August 28, 2014) | 150,000 | 300,000 | ||||
Cameron Meierhoefer | 450,000 | 900,000 | ||||
Christiana Lin | 450,000 | 900,000 |
Performance Measure | Threshold Performance | Target Performance | Maximum Performance |
Revenue | $311 million | $322 million | $334 million |
Adjusted EBITDA | $57.5 million | $63.0 million | $70.5 million |
Name | Corporate Performance Objective - Revenue | Corporate Performance Objective - Adjusted EBITDA |
Serge Matta | 50% | 50% |
Gian M. Fulgoni | N/A | 100% |
Kenneth J. Tarpey (retired August 28, 2014) | N/A | 100% |
Cameron Meierhoefer | N/A | 100% |
Christiana Lin | N/A | 100% |
Performance Measure | Target Performance Level | Actual Performance Level | Performance as a Percentage of Target |
Revenue | $322 million | $329.2 million | 165 % |
Adjusted EBITDA | $63.0 million | $71.37 million | 200 % |
Name (1) | Target Annual Incentive Award Opportunity ($) | Actual Annual Incentive Award ($) | Actual Annual Incentive Award (number of shares) (2) | Actual Annual Incentive Achieved Against Target (%) | ||||||
Serge Matta | $ | 700,000 | $ | 1,287,775 | 29,629 | 184 | % | |||
Gian M. Fulgoni | 275,000 | 500,000 | 11,585 | 200 | % | |||||
Melvin Wesley III | 450,000 | 900,000 | 20,853 | 200 | % | |||||
Cameron Meierhoefer | 450,000 | 900,000 | 20,853 | 200 | % | |||||
Christiana Lin | 450,000 | 900,000 | 20,853 | 200 | % |
(1) | Mr. Tarpey did not receive an annual incentive award because he retired from the Company during 2014. |
(2) | The number of shares of our common stock received was determined based on the closing price of our common stock reported on the NASDAQ Global Select Market on February 11, 2015, which was $43.16 per share. |
Name (1) | Long-Term Time-Based Equity Award ($) | Long-Term Time-Based Award (number of shares) (2) |
Serge Matta | $700,000 | 16,219 |
Gian M. Fulgoni | N/A | N/A |
Melvin Wesley III(3) | 300,000 | 6,951 |
Cameron Meierhoefer | 300,000 | 6,951 |
Christiana Lin | 300,000 | 6,951 |
(1) | Mr. Tarpey did not receive an additional time-based long-term incentive award because he retired from the Company during 2014. |
(2) | The number of shares of our common stock received was determined based on the closing price of our common stock reported on the NASDAQ Global Select Market on February 11, 2015, which was $43.16 per share. These awards immediately vested as to one-third of such shares upon the date of determination by our Compensation Committee in 2015, and the remaining two-thirds of such shares vest in two equal installments on the firsts and second anniversaries of the date of determination by our Compensation Committee, subject to continued employment through each of the vesting dates. |
(3) | Mr. Wesley's time-based long-term incentive award was approved by our Compensation Committee when he joined us as our Chief Financial Officer in August, 2014. |
Stock-Price Target (per share) (1) | Percentage of Shares Subject to Stock Option That Will Become Exercisable | Percentage of Shares Subject to RSU Award That Will Vest | |
$48.00 | 66 % | 48 % | |
$50.00 | 10 % | 10 % | |
$55.00 | 14 % | 22 % | |
$60.00 | 10 % | 20 % |
(1) | Each stock-price target will be deemed satisfied when the closing market price of our common stock as reported by the NASDAQ Global Market exceeds the average of the target stock price for a consecutive 30-day period prior to November 17, 2017 |
Name | Stock Option (number of shares) | Restricted Stock Unit Award (number of shares) |
Serge Matta | 984,727 | 141,678 |
Melvin Wesley III | 218,828 | 31,484 |
Cameron Meierhoefer | 218,828 | 31,484 |
Christiana Lin | 218,828 | 31,484 |
• | health and dental insurance; |
• | life insurance; |
• | short-and long-term disability; and |
• | a Section 401(k) plan. |
Name and Principal Position | Year($) | Salary ($) | Stock Awards ($)(1) | Option Awards ($)(1) | All Other Compensation ($) | Total ($) |
Serge Matta President, Chief Executive Officer and Director | 2014 2013 2012 | $466,594 382,512 328,749 | $8,008,208(2) 2,981,384 1,098,484 | $8,547,430(3) ---- ---- | $3,137(4) 3,077 3,557 | $17,025,369 3,366,963 1,430,790 |
Magid M. Abraham, Ph.D. Executive Chairman of the Board of Directors | 2014 2013 2012 | 250,049(5) 500,000 500,008 | 3,044,012(6) 1,563,089(7) 6,673,052(8) | ---- ---- ---- | 214(4) 213 176 | 3,294,275 2,063,302 7,173,236 |
Gian M. Fulgoni Chairman Emeritus and Director | 2014 2013 2012 | 375,079(9) 375,000 375,005 | 1,150,000(10) 2,158,895 1,001,600 | ---- ---- ---- | 367(4) 359 392 | 1,525,446 2,534,254 1,376,997 |
Melvin Wesley III Chief Financial Officer (hired August 29, 2014) | 2014 | 107,897 | 2,374,921(11) | 1,899,427(12) | 846(4) | 4,383,092 |
Cameron Meierhoefer Chief Operating Officer | 2014 2013 2012 | 342,333 315,750 293,749 | 2,491,271(13) 1,411,262 1,025,600 | 1,899,427(12) ---- ---- | 1,950(4) 1,929 1,207 | 4,734,981 1,728,941 1,320,556 |
Christiana Lin Executive Vice President, General Counsel and Chief Privacy Officer | 2014 | 322,833 | 2,476,271(14) | 1,899,427(12) | 2,073(4) | 4,700,604 |
Kenneth J. Tarpey (former Chief Financial Officer, retired August 28, 2014) | 2014 2013 2012 | 247,784 363,125 341,249 | 282,484(15) 1,525,138 849,100 | ---- ---- ---- | 121,788(16) 2,175 3,785 | 652,056 1,890,438 1,194,134 |
(1) | Amounts represent the aggregate grant date fair value of stock and option awards computed in accordance with Financial Accounting Standards Board Accounting Standards Codification Topic 718, Compensation-Stock Compensation (FASB ASC Topic 718). Assumptions used in the calculation of these amounts are described in Note 11 to the consolidated financial statements included in Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2014. |
(2) | Includes a promotion grant of 44,459 restricted stock units awarded on March 3, 2014, with 22,230 shares to be earned on achievement against 2014 company-level performance objectives, and 22,229 shares to vest in three equal installments in February 2015, 2016 and 2017. Includes a market-based restricted stock unit grant awarded in November 7, 2014, of 141,678 shares to vest upon the achievement of pre-established stock-price targets, using a valuation of $31.82 per share performed under guidance found in Accounting Standards Codification 718. This restricted stock unit grant would vest in four increments with 68,401 shares, 13,686 shares, 31,091 shares and 28,500 shares vesting if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $60.00, respectively; no vesting from this award occurred in 2014. Includes a performance-based annual target incentive with a fair value of $700,000 computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined 2014 revenue, and Adjusted EBITDA milestones. Includes a performance-based long-term target incentive with a fair value of $700,000 computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined 2014 revenue, and Adjusted EBITDA milestones. On February 11, 2015, because we surpassed our pre-established consolidated revenue and Adjusted EBITDA targets, an annual incentive of $1,278,775 was actually awarded. Also on February 11, 2015, because we surpassed our pre-established consolidated revenue and Adjusted EBITDA targets, a performance-based long-term incentive of $1,278,775 was awarded with vesting in three equal installments in February 2015, 2016, and 2017. |
(3) | Includes a market-based stock option award of the option to purchase 984,727 shares of our common stock with an exercise price of $42.92 per share with a valuation of $8.68 per share using the Black-Scholes option-pricing formula and single option award approach. The fair value of market-based stock options is determined using a Monte Carlo simulation embedded in a lattice model. The Company then amortizes the fair value of awards expected to vest on a ratable straight-line basis over the requisite service periods of the awards, which is generally the period from the grant date to the end of the vesting period. The stock option award would become exercisable in four increments with 646,400 shares, 96,651 shares, 141,558 shares and 100,118 shares exercisable if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $60.00, respectively; no vesting of this award occurred in 2014. |
(4) | Includes discretionary matching contributions by us to the officer’s 401(k) plan account and payment of life insurance premiums on behalf of the named executive officers. |
(5) | Includes $234,049 computed in accordance with FASB ASC Topic 718, received in restricted stock units in lieu of cash salary from January 1, 2014 through December 31, 2014 with the remainder paid in cash during 2014 to cover health benefits. |
(6) | Represents a performance-based restricted stock unit award made pursuant to the provisions of our 2012 Chief Executive Officer Bonus Policy, to vest over three equal annual tranches, based on performance targets established in the beginning of each measurement year. At his request, upon transition to Executive Chairman, 96,666 shares of our common stock originally granted would remain in force subject to the achievement of performance objectives established in 2014. In 2014, performance criteria were approved by our Compensation Committee on February 28, 2014, with a fair value of $3,044,012, computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined revenue, EBITDA, and product related milestones in 2014. On February 11, 2015, because we surpassed our pre-established consolidated revenue and Adjusted EBITDA targets, 100% of these performance-based shares (or 96,666) vested, and an additional 19,982 performance-based restricted stock units vested with a total vest date fair value of $3,673,222 computed in accordance with FASB ASC Topic 718 for over-achievement of pre-established goals. |
(7) | Represents a performance-based award related to our 2012 Equity Incentive Plan granted on March 29, 2012, in restricted stock pursuant to the provisions of our 2012 Chief Executive Officer Bonus Policy, to vest over three equal annual tranches, based on performance targets established in the beginning of each measurement year. In 2013, performance criteria were approved by our Compensation Committee on April 30, 2013, with a fair value of $1,563,089 computed in accordance with FASB ASC Topic 718, to vest on March 30, 2014 upon achievement of pre-determined revenue and Adjusted EBITDA milestones in 2013. On March 30, 2014, because we surpassed our pre-established consolidated revenue and Adjusted EBITDA targets, 100% of these performance-based shares (or 96,666) vested, and an additional 65,620 performance-based restricted stock units vested with a vest date fair value of $5,160,263 computed in accordance with FASB ASC Topic 718 for over-achievement of pre-established goals. The table does not reflect the shares subject to 2014 performance, for which performance goals have not been established. |
(8) | Represents a performance-based award related to our 2012 Equity Incentive Plan granted on March 29, 2012, in restricted stock pursuant to the provisions of our 2012 Chief Executive Officer Bonus Policy, with a grant date fair value of $2,103,452 computed in accordance with FASB ASC Topic 718, to vest on March 30, 2013 upon achievement of pre-determined revenue and Adjusted EBITDA milestones in 2012. On March 30, 2013, 100% of these performance-based shares were canceled due to failure to achieve pre-determined milestones during 2012. Also represents a grant to Dr. Abraham of 210,000 shares, awarded on March 29, 2012, made for retention purposes with vesting over a 4-year period in March 2013, 2014, 2015, and 2016 respectively. |
(9) | Includes $332,079 computed in accordance with FASB ASC Topic 718, received in restricted stock units in lieu of cash salary from January 1, 2014 through December 31, 2014 with the remainder paid in cash during 2014 to cover health benefits. |
(10) | Includes a performance-based annual target incentive with a fair value of $375,000 computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined 2014 revenue and management based objectives. Includes a performance-based long-term target incentive with a fair value of $275,000 computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined 2014 Adjusted EBITDA milestones. On February 11, 2015, because we surpassed our pre-established consolidated revenue target, an annual incentive of $571,093 was actually awarded. Also on February 11, 2015, because we surpassed our pre-established Adjusted EBITDA target, a performance-based long-term incentive of $500,000 was awarded with vesting in three equal installments in February 2015, 2016, and 2017. |
(11) | Includes a new hire grant of 10,000 shares of our common stock awarded on August 29, 2014, with vesting in three equal installments in August 2015, 2016 and 2017. Includes a market-based restricted stock unit grant awarded in November 7, 2014, of 31,484 shares to vest upon the achievement of pre-established stock-price targets, using a valuation of $31.82 per share performed under guidance found in Accounting Standards Codification 718. This restricted stock unit grant is earned in four increments with 15,112 shares, 3,148 shares, 6,926 shares and 6,297 shares vesting if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $50.00, respectively; no vesting from this award occurred in 2014. Includes a performance-based annual target incentive with a fair value of $240,000 computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined 2014 revenue and Adjusted EBITDA milestones, as well as management based objectives. Includes a performance-based long-term target incentive with a fair value of $450,000 computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined Adjusted EBITDA milestones. On February 11, 2015, because we surpassed our pre-established consolidated revenue and Adjusted EBITDA targets, an annual incentive of $383,128 was actually awarded. Also on February 11, 2015, because we surpassed our pre-established Adjusted EBITDA target, a performance-based long-term incentive of $900,000 was awarded with vesting in three equal installments in February 2015, 2016, and 2017. |
(12) | Includes a market-based stock option award of the option to purchase 218,828 shares of our common stock with an exercise price of $42.92 per share with a valuation of $8.68 per share using the Black-Scholes option-pricing formula and single option award approach. The fair value of market-based stock options is determined using a Monte Carlo simulation embedded in a lattice model. The Company then amortizes the fair value of awards expected to vest on a ratable straight-line basis over the requisite service periods of the awards, which is generally the period from the grant date to the end of the vesting period. The stock option award would become exercisable in four increments with 144,426 shares, 21,883 shares, 30,636 shares and 21,883 shares exercisable if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $60.00, respectively; no vesting of this award occurred in 2014. |
(13) | Includes a one- time grant of 15,000 shares of our common stock awarded on May 1, 2014, with 7,500 shares to be earned on achievement against 2014 company-level performance objectives, and 7,500 shares to vest in three equal installments in February 2015, 2016 and 2017. Includes a market-based restricted stock unit grant awarded in November 7, 2014, of 31,484 shares to vest upon the achievement of pre-established stock-price targets, using a valuation of $31.82 per share performed under guidance found in Accounting Standards Codification 718. This restricted stock unit grant is earned in four increments with 15,112 shares, 3,148 shares, 6,926 shares and 6,297 shares vesting if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $50.00, respectively; no vesting from this award occurred in 2014. Includes a performance-based annual target incentive with a fair value of $265,000 computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined 2014 revenue milestones and management based objectives. Includes a performance-based long-term target incentive with a fair value of $450,000 computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined Adjusted EBITDA milestones. On February 11, 2015, because we surpassed our pre-established consolidated revenue, an annual incentive of $340,951 was actually awarded. Also on February 11, 2015, because we surpassed our pre-established Adjusted EBITDA target, a performance-based long-term incentive of $900,000 was awarded with vesting in three equal installments in February 2015, 2016, and 2017. |
(14) | Includes a one- time grant of 15,000 shares of our common stock awarded on May 1, 2014, with 7,500 shares to be earned on achievement against 2014 company-level performance objectives, and 7,500 shares to vest in three equal installments in February 2015, 2016 and 2017. Includes a market-based restricted stock unit grant awarded in November 7, 2014, of 31,484 shares to vest upon the achievement of pre-established stock-price targets, using a valuation of $31.82 per share performed under guidance found in Accounting Standards Codification 718. This restricted stock unit grant is earned in four increments with 15,112 shares, 3,148 shares, 6,926 shares and 6,297 shares vesting if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $50.00, respectively; no vesting from this award occurred in 2014. Includes a performance-based annual target incentive with a fair value of $250,000 computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined management based objectives. Includes a performance-based long-term target incentive with a fair value of $450,000 computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined Adjusted EBITDA milestones. On February 11, 2015, an annual incentive of $249,750 was actually awarded. Also on February 11, 2015, because we surpassed our pre-established Adjusted EBITDA target, a performance-based long-term incentive of $900,000 was awarded with vesting in three equal installments in February 2015, 2016, and 2017. |
(15) | Includes $243,174 computed in accordance with FASB ASC Topic 718 received in restricted stock units vesting immediately upon retirement pursuant to the terms of the Mr. Tarpey's Transition Agreement. Also includes a grant with a fair value of $39,310 representing shares awarded post-departure in connection with Mr. Tarpey's appointment to the Company's advisory board. |
(16) | Includes severance payment of $119,716 pursuant to the terms of the Mr. Tarpey's Transition Agreement. |
Approval Date | Estimated Future Payouts Under Equity Incentive Plan Awards (1) | All Other Stock Awards: Number of Shares of Stock (#) | All Other Option Awards: Number of Securities Underlying Options (#) | Exercise or Base Price of Option Awards ($/Sh) | Grant Date Fair Value of Stock and Option Awards($)(2) | |||||||
Name | Grant Date | Target ($) | Maximum($) | Target (#) | Maximum (#) | |||||||
Serge Matta | 3/3/2014 | 2/28/2014 | — | — | — | — | 22,229(3) | — | — | $699,991 | ||
3/3/2014 | 2/28/2014 | — | — | 22,230(4) | — | — | — | — | 700,023 | |||
11/7/2014 | 11/7/2014 | — | — | 141,678(5) | — | — | — | — | 4,508,194 | |||
11/7/2014 | 11/7/2014 | — | — | — | — | — | 984,727(6) | $42.92 | 8,547,430 | |||
(7) | (7) | $700,000 | $1,400,000 | — | — | — | — | — | 700,000(8) | |||
(7) | (7) | $700,000 | $1,400,000 | — | — | — | — | — | 700,000(9) | |||
(7) | (7) | $700,000 | — | — | — | — | — | — | 700,000(10) | |||
Magid M. Abraham, Ph.D | 3/3/2014(11) | 2/28/2014 | — | — | 96,666(12) | 144,999(12) | — | — | — | 3,044,012 | ||
3/31/2014 | 2/28/14 | — | — | — | — | 1,785(13) | — | — | 58,530 | |||
6/30/2014 | 2/28/14 | — | — | — | — | 1,649(13) | — | — | 58,507 | |||
9/30/2014 | 2/28/14 | — | — | — | — | 1,607(13) | — | — | 58,511 | |||
12/31/2014 | 2/28/14 | — | — | — | — | 1,260(13) | — | — | 58,502 | |||
Gian M. Fulgoni | 3/31/2014 | 2/28/14 | — | — | — | — | 2,532(13) | — | — | 83,024 | ||
6/30/2014 | 2/28/14 | — | — | — | — | 2,340(13) | — | — | 83,023 | |||
9/30/2014 | 2/28/14 | — | — | — | — | 2,280(13) | — | — | 83,015 | |||
12/31/2014 | 2/28/14 | — | — | — | — | 1,788(13) | — | — | 83,017 | |||
(7) | (7) | $375,000 | $750,000 | — | — | — | — | — | 375,000(14) | |||
(7) | (7) | $275,000 | $500,000 | — | — | — | — | — | 275,000(15) | |||
(7) | (7) | $500,000 | — | — | — | — | — | — | 500,000(10) | |||
Melvin Wesley III | 8/29/2014 | 8/1/2014 | — | — | — | — | 10,000(16) | — | — | 383,100 | ||
11/7/2014 | 11/7/2014 | — | — | 31,484(17) | — | — | — | — | 1,001,821 | |||
11/7/2014 | 11/7/2014 | — | — | — | — | — | 218,828(18) | $42.92 | 1,899,427 | |||
(7) | (7) | $240,000 | $480,000 | — | — | — | — | — | 240,000(19) | |||
(7) | (7) | $450,000 | $900,000 | — | — | — | — | — | 450,000(15) | |||
(7) | (7) | $300,000 | — | — | — | — | — | — | 300,000(10) | |||
Cameron Meierhoefer | 5/1/2014 | 4/15/2014 | — | — | — | — | 7,500(3) | — | — | 237,225 | ||
5/1/2014 | 4/15/2014 | — | — | 7,500 | (4) | — | — | — | — | 237,225 | ||
11/7/2014 | 11/7/2014 | — | — | 31,484 | (17) | — | — | — | — | 1,001,821 | ||
11/7/2014 | 11/7/2014 | — | — | — | — | — | 218,828(18) | $42.92 | 1,899,427 | |||
(7) | (7) | $265,000 | $530,000 | — | — | — | — | — | 265,000(14) | |||
(7) | (7) | $450,000 | $900,000 | — | — | — | — | — | 450,000(15) | |||
(7) | (7) | $300,000 | — | — | — | — | — | — | 300,000(10) | |||
Christiana Lin | 5/1/2014 | 4/15/2014 | — | — | — | — | 7,500(3) | — | — | 237,225 | ||
5/1/2014 | 4/15/2014 | — | — | 7,500(4) | — | — | — | — | 237,225 | |||
11/7/2014 | 11/7/2014 | — | — | 31,484(17) | — | — | — | — | 1,001,821 | |||
11/7/2014 | 11/7/2014 | — | — | — | — | — | 218,828(18) | $42.92 | 1,899,427 | |||
(7) | (7) | $250,000 | $500,000 | — | — | — | — | — | 250,000(14) | |||
(7) | (7) | $450,000 | $900,000 | — | — | — | — | — | 450,000(15) | |||
(7) | (7) | $300,000 | — | — | — | — | — | — | 300,000(10) |
Approval Date | Estimated Future Payouts Under Equity Incentive Plan Awards (1) | All Other Stock Awards: Number of Shares of Stock (#) | All Other Option Awards: Number of Securities Underlying Options (#) | Exercise or Base Price of Option Awards ($/Sh) | Grant Date Fair Value of Stock and Option Awards($)(2) | |||||||
Name | Grant Date | Target ($) | Maximum($) | Target (#) | Maximum (#) | |||||||
Kenneth J. Tarpey (retired August 29, 2014) | 8/15/2014 | 7/22/2014 | — | — | — | — | 6,205(20) | — | — | 243,174 | ||
9/2/2014 | 9/2/2014 | — | — | — | — | 1,000(21) | — | — |
(1) | The target and maximum incentive award amounts shown in this column reflect the value of the short- and long-term incentive compensation available to our named executive officers pursuant to our 2014 executive incentive compensation policy. The amounts representing the target awards were pre-established as a percentage of salary. The maximum is the greatest payout which can be made if the pre-established maximum performance level is met or exceeded. The policy also provides that the entire award amount shall be paid in shares of restricted stock valued at the time of grant. Actual awards under our 2014 executive incentive compensation policy were approved on February 11, 2015 and are reflected in the Stock Award column of the Summary Compensation Table above for 2014 in each case for each named executive officer. |
(2) | Amounts represent fair value of awards as calculated in accordance with FASB ASC Topic 718 and as further described in Note 11 to the consolidated financial statements included in Item 8 of our Annual Report on Form 10-K for the year ended December 31, 2014. |
(3) | One-time restricted stock unit award to vest in three equal installments in February 2015, 2016 and 2017. |
(4) | One-time restricted stock unit award to be earned based on achievement against 2014 company-level performance objectives, with achievement amounts determined in February 2015. |
(5) | Market-based restricted stock unit grant awarded in November 7, 2014, to be earned on achievement of pre-established stock-price targets, using a valuation of $31.82 per share performed under guidance found in Accounting Standards Codification 718. This restricted stock unit grant will be earned in four increments with 68,401 shares, 13,686 shares, 31,091 shares and 28,500 shares, respectively, if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $60.00, respectively; no shares were earned under this award in 2014. |
(6) | Market-based stock option award of the option to purchase 984,727 shares of our common stock with an exercise price of $42.92 per share with a valuation of $8.68 per share using the Black-Scholes option-pricing formula and single option award approach. The fair value of market-based stock options is determined using a Monte Carlo simulation embedded in a lattice model. The Company then amortizes the fair value of awards expected to vest on a ratable straight-line basis over the requisite service periods of the awards, which is generally the period from the grant date to the end of the vesting period. The stock option award would become exercisable in four increments with 646,400 shares, 96,651 shares, 141,558 shares and 100,118 shares exercisable if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $60.00, respectively; no vesting of this award occurred in 2014. |
(7) | On February 28, 2014, our Compensation Committee established our 2014 Executive Compensation Bonus Policy to include target annual incentives, target long-term performance-based incentives, and long-term time-based incentives. These incentives would be awarded in February 2015, after our Compensation Committee determined actual achievement against targets (for the performance-based incentive components), and subject to the named executive officer's continued service on the determination date. |
(8) | Annual incentive award levels pursuant to 2014 Executive Compensation Bonus Policy. 50% of the award amount was based on achievement of pre-determined 2014 revenue target levels and 50% of the award amount was based on achievement against 2014 adjusted EBITDA target levels as discussed in Incentive Compensation. Actual achievement against 2014 revenue targets was 165%, and actual achievement against 2014 Adjusted EBITDA targets was 200%. The determination date for these achievement amounts was February 11, 2015, and 100% of the award was immediately vested. |
(9) | Long-term performance-based award levels pursuant to 2014 Executive Compensation Bonus Policy. 50% of the award amount was based on achievement against 2014 revenue target levels and 50% of the award amount was based on achievement against 2014 Adjusted EBITDA target levels as discussed in Incentive Compensation. Actual achievement against 2014 revenue targets was 165%, and actual achievement against 2014 Adjusted EBITDA targets was 200%. The determination date for these achievement amounts was February 11, 2015, and 1/3 of the award amount was immediately vested in February 2015 with 1/3 vesting in each of February 2016 and February 2017. |
(10) | As part of the 2014 Executive Compensation Bonus Policy, our Compensation Committee would grant the named executive officer a time-based long-term incentive award in an amount equal to the amount with a value set forth in the “Target” column. The determination date for these awards was February 11, 2015, and 1/3 of the award amount was immediately vested in February 2015 with 1/3 vesting in each of February 2016 and February 2017. |
(11) | Based on our 2012 Chief Executive Officer Bonus Policy, restricted stock and restricted stock units were awarded to Dr. Abraham, to vest over three equal annual tranches, based on performance targets established in the beginning of each measurement year. The “Grant Date” represents the date on which the Dr. Abraham’s 2014 performance criteria were approved by our Compensation Committee. |
(12) | Performance-based restricted stock unit award made pursuant to the provisions of our 2012 Chief Executive Officer Bonus Policy, to vest over three equal annual tranches, based on performance targets established in the beginning of each measurement year. At his request, upon transition to Executive Chairman, 96,666 shares of our common stock originally granted would remain in force subject to the achievement of performance objectives established in 2014, and 50% of the 96,666 share of our common stock originally granted for the purpose of recognizing overachievement against performance objectives would remain in force. In 2014, performance criteria were approved by our Compensation Committee on February 28, 2014, with a fair value of $3,044,012, computed in accordance with FASB ASC Topic 718, to vest in February 2015 upon achievement of pre-determined revenue, EBITDA, and product related milestones in 2014. On February 11, 2015, because we surpassed our pre-established consolidated revenue and Adjusted EBITDA targets, 100% of these performance-based shares (or 96,666) vested, and an additional 19,982 performance-based restricted stock units vested with a vest date fair value of $3,673,222 computed in accordance with FASB ASC Topic 718 for over-achievement of pre-established goals. |
(13) | Restricted stock units awarded in lieu of cash salary. |
(14) | Annual incentive award levels pursuant to 2014 Executive Compensation Bonus Policy. Award amount was based on achievement against 2014 revenue target levels and individual performance objectives as discussed in Incentive Compensation. The actual achievement against 2014 revenue target was 165%. |
(15) | Long-term performance-based award levels pursuant to 2014 Executive Compensation Bonus Policy. Award amount was based on achievement against 2014 Adjusted EBITDA target levels as discussed in Incentive Compensation. Actual achievement against 2014 Adjusted EBITDA targets was 200%. 1/3 of the award amount was immediately vested in February 2015 with 1/3 vesting in each of February 2016 and February 2017. |
(16) | Represents a new hire grant of 10,000 shares of our common stock awarded on August 29, 2014, with vesting in three equal installments in August 2015, 2016 and 2017. |
(17) | Market-based restricted stock unit grant awarded in November 7, 2014, of 31,484 shares to vest upon the achievement of pre-established stock-price targets, using a valuation of $31.82 per share performed under guidance found in Accounting Standards Codification 718. This restricted stock unit grant would vest in four increments with 15,112 shares, 3,148 shares, 6,926 shares and 6,297 68,401 shares, 13,686 shares, 31,091 shares and 28,500 shares vesting if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $60.00, respectively; no shares were earned from this award in 2014. |
(18) | Market-based stock option award of the option to purchase 218,828 shares of our common stock with an exercise price of $42.92 per share with a valuation of $8.68 per share using the Black-Scholes option-pricing formula and single option award approach. The fair value of market-based stock options is determined using a Monte Carlo simulation embedded in a lattice model. The Company then amortizes the fair value of awards expected to vest on a ratable straight-line basis over the requisite service periods of the awards, which is generally the period from the grant date to the end of the vesting period. The stock option award would become exercisable in four increments with 144,426 shares, 21,883 shares, 30,636 shares and 21,883 shares exercisable if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $60.00, respectively; no vesting of this award occurred in 2014. |
(19) | Annual incentive award levels pursuant to 2014 Executive Compensation Bonus Policy. Award amount was based on achievement against 2014 revenue and adjusted EBITDA target levels and management based objectives as discussed in Incentive Compensation. The actual achievement against 2014 revenue target and Adjusted EBITDA were 165% and 200% respectively. |
(20) | On May 8, 2014, the Company announced Mr. Tarpey's intention to retire and the entry into a Transition Agreement with Mr. Tarpey dated May 5, 2014 (the "Transition Agreement"). Under the terms of the Transition Agreement, Mr. Tarpey received a one-time distribution of shares based on a pro-rated calculation of his 2014 short-term incentive and the immediately vested performance-based portion of his 2014 long-term incentive pursuant to the Company's 2014 executive incentive plan. The incentive achievement amounts were determined based on the Company's first and second quarter revenue and Adjusted EBITDA results relative to the targets, with the assumption that Mr. Tarpey achieved 100% of of any management based objectives for those periods. No overachievement was assumed or allocated. |
(21) | One-time award to vest on the one year anniversary of grant date, for the purpose of providing transition services after Mr. Tarpey's departure. |
Option Awards | Stock Awards | |||||||
Option Exercise Price ($) | Option Expiration Date | Number of Shares of Stock That Have Not Vested (#)(1) | Market Value of Shares of Stock That Have Not Vested ($)(1) | Equity Incentive Plan Awards | ||||
Name | Equity Incentive Plan Awards: Unexercised and Unearned (#) | Unearned Shares That Have Not Vested (#) | Market Value of Unearned Shares That Have Not Vested ($) | |||||
Serge Matta | — | — | — | 7500(2) | 348,225 | — | — | |
— | — | — | 2,268(3) | 105,303 | — | — | ||
— | — | — | 17,500(4) | 812,526 | — | — | ||
— | — | — | 4,858(5) | 225,557 | — | — | ||
— | — | — | 33,334(6) | 1,547,698 | — | — | ||
— | — | — | 25,110(7) | 1,165,858 | — | — | ||
— | — | — | 22,229(8) | 1,032,092 | — | — | ||
— | — | — | 22,230(9) | 1,032,139 | — | — | ||
— | — | — | — | — | 141,678(10) | $6,578,110 | ||
984,727(11) | $42.92 | 11/4/2017 | — | — | — | — | ||
Magid M. Abraham, Ph.D. | — | — | — | 9,981(12) | 463,418 | — | — | |
— | — | — | 70,000(13) | 3,250,100 | — | — | ||
— | — | — | 145,000(14) | 6,732,350 | — | — | ||
Gian M. Fulgoni | — | — | — | 17,500(15) | 812,525 | — | — | |
— | — | — | 6,695(16) | 310,849 | — | — | ||
— | — | — | 16,667(17) | 773,849 | — | — | ||
— | — | — | 6,695(18) | 310,849 | — | — | ||
Melvin Wesley III | — | — | — | 10,000(19) | 464,300 | — | — | |
— | — | — | — | — | 31,484(20) | $2,221,954 | ||
218,828(21) | $42.92 | 11/4/2017 | — | — | — | — | ||
Cameron Meierhoefer | — | — | — | 1,542(22) | 71,595 | — | — | |
— | — | — | 17,500(23) | 812,525 | — | — | ||
— | — | — | 3,807(24) | 176,759 | — | — | ||
— | — | — | 16,667(25) | 773,849 | — | — | ||
— | — | — | 12,555(26) | 582,929 | — | — | ||
— | — | — | 15,000(27) | 696,450 | — | — | ||
— | — | — | — | — | 31,484(20) | $2,221,954 | ||
218,828(21) | $42.92 | 11/4/2017 | — | — | — | — | ||
Option Awards | Stock Awards | |||||||
Option Exercise Price ($) | Option Expiration Date | Number of Shares of Stock That Have Not Vested (#)(1) | Market Value of Shares of Stock That Have Not Vested ($)(1) | Equity Incentive Plan Awards | ||||
Name | Equity Incentive Plan Awards: Unexercised and Unearned (#) | Unearned Shares That Have Not Vested (#) | Market Value of Unearned Shares That Have Not Vested ($) | |||||
Christiana Lin | — | — | — | 1,652(28) | 76,702 | — | — | |
— | — | — | 12,500(29) | 580,376 | — | — | ||
— | — | — | 3,628(30) | 168,448 | — | — | ||
— | — | — | 16,667(31) | 773,849 | — | — | ||
— | — | — | 12,555(32) | 582,929 | — | — | ||
— | — | — | 15,000(33) | 696,450 | — | — | ||
— | — | — | — | — | 31,484(20) | $2,221,954 | ||
218,828(21) | $42.92 | 11/4/2017 | — | — | — | — | ||
Kenneth J. Tarpey (retired August 28, 2014) | — | — | — | 1,000(34) | — | — | $39,310 |
(1) | Market value of shares of stock that have not vested is computed based on $46.43 per share, which was the closing price of our common stock as reported on the NASDAQ Global Market on December 31, 2014. For a description of this award see the Compensation Discussion and Analysis section titled Annual Incentive Compensation for Dr. Abraham. |
(2) | comScore’s right of repurchase lapses for 7,500 shares annually on February 18, contingent upon Mr. Matta's continued service as of each such date. |
(3) | comScore’s right of repurchase lapses for 2,268 shares annually on March 15, contingent upon Mr. Matta's continued service as of each such date. |
(4) | comScore’s right of repurchase lapses for 8,750 shares annually on March 15, contingent upon Mr. Matta's continued service as of each such date. |
(5) | Restricted stock unit award with 4,858 shares vesting annually on March 15, contingent upon Mr. Matta's continued service as of each such date. |
(6) | Restricted stock unit award with 16,667 shares vesting annually on February 18, contingent upon Mr. Matta's continued service as of each such date. |
(7) | Restricted stock unit award with 12,555 shares vesting annually on February 18, contingent upon Mr. Matta's continued service as of each such date. |
(8) | Restricted stock unit award with 7,335, 7,336 and 7,558 shares vesting annually beginning February 18, 2015, contingent upon Mr. Matta's continued service as of each such date. |
(9) | Restricted stock unit award with 7,335, 7,336 and 7,559 shares vesting annually beginning February 18, 2015, contingent upon Mr. Matta's continued service as of each such date. |
(10) | Restricted stock unit award subject to market based vesting. Award earned in four increments with 68,401 shares, 13,686 shares, 31,091 shares and 28,500 shares vesting if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $50.00, respectively. The award vested with respect to 68,401 shares on March 1, 2015 and 13,686 shares on March 8, 2015. |
(11) | Stock options award subject to market based vesting. Award earned in four increments with 646,400 shares, 96,651 shares, 141,558 shares and 100,118 shares exercisable if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $50.00, respectively. The award became exercisable with respect to 646,400 shares on March 1, 2015 and 96,651 shares on March 8, 2015. |
(12) | comScore’s right of repurchase lapses for 9,981 shares annually on March 15, contingent upon Dr. Abraham’s continued service as of each such date. |
(13) | comScore’s right of repurchase lapses for 70,000 shares annually on March 30, contingent upon Dr. Abraham’s continued service as of each such date. |
(14) | On March 29, 2012, Dr. Abraham was awarded 580,000 shares of our common stock in the form of restricted stock and restricted stock units that vest based on achievement of revenue andAdjusted EBITDAA goals during 2012, 2013 and 2014. In 2014, Dr. Abraham becomes eligible to earn up to 96,666 shares for achieving 100% of pre-established revenue and Adjusted EBITDA targets. In 2014, this award was adjusted to reflect Dr. Abraham's change in role to Executive Chairman. As a result, in 2014, Dr. Abraham is eligible to earn up to 96,666 shares for achieving 100% of pre-established revenue, Adjusted EBITDA, and product-specific goals, and an additional 48,333 shares for overachieving against pre-established revenue, Adjusted EBITDA, and product development targets. Any unearned shares from prior years have been canceled. |
(15) | comScore’s right of repurchase lapses for 8,333 shares on March 15, 2015 and 8,334 shares on March 15, 2016, contingent upon Mr. Fulgoni’s continued service as of each such date. |
(16) | comScore’s right of repurchase lapses for 6,695 shares on March 15, 2015 contingent upon Mr. Fulgoni's continued service on such date. |
(17) | Restricted stock unit awards with 8,333 shares vesting on February 18, 2015 and 8,334 shares vesting on February 18, 2016, contingent upon Mr. Fulgoni’s continued service as of each such dates. |
(18) | Restricted stock unit awards with 3,461 shares vesting on March 15, 2015, contingent upon Mr. Fulgoni's continued service on such date. |
(19) | Restricted stock unit awards with 3,300 shares vesting on each of August 15, 2015 and August 15, 2016 and 3,400 shares vesting August 15, 2017, contingent upon Mr. Wesley's continued service as of each such date. |
(20) | Restricted stock unit award subject to market based vesting. Award earned in four increments with 15,112 shares, 3,148 shares, 6,926 shares and 6,297 shares vesting if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day period exceeds $48.00, $50.00, $55.00, and $50.00, respectively. The award vested with respect to 15,112 shares on March 1, 2015 and 3,148 shares on March 8, 2015. |
(21) | Stock options award subject to market based vesting. Award earned in four increments with 144,426 shares, 21,883 shares, 30,636 shares and 21,883 shares exercisable if the average daily closing price of the Company's common stock on the NASDAQ Global Market during any consecutive thirty-day |
(22) | comScore’s right of repurchase lapses for 1,542 shares on March 15, 2015, contingent upon Mr. Meierhoefer's continued service on such date. |
(23) | comScore’s right of repurchase lapses for 8,750 shares annually on March 15, contingent upon Mr. Meierhoefer's continued service as of each such date. |
(24) | Restricted stock unit awards with 3,807 shares vesting on March 15, 2015, contingent upon Mr. Meierhoefer's continued service on such date. |
(25) | Restricted stock unit awards with 8,333 shares vesting on February 18, 2015 and 8,334 shares vesting on February 18, 2016, contingent upon Mr. Meierhoefer's continued service as of each such date. |
(26) | Restricted stock unit awards with 6,277 shares vesting on February 18, 2015 and 6,278 shares vesting on February 18, 2016, contingent upon Mr. Meierhoefer's continued service as of each such date. |
(27) | Restricted stock unit awards with 4,950 shares vesting on February 18, 2015, 4,950 shares vesting on February 18, 2016, and 5,100 shares vesting on February 18, 2017, contingent upon Mr. Meierhoefer's continued service as of each such date. |
(28) | comScore’s right of repurchase lapses for 1,652 shares on March 15, 2015, contingent upon Ms. Lin's continued service on such date. |
(29) | comScore’s right of repurchase lapses for 6,250 shares annually on March 15, contingent upon Ms. Lin's continued service on such date. |
(30) | Restricted stock unit awards with 3,628 shares vesting on March 15, 2015, contingent upon Ms. Lin's continued service on such date. |
(31) | Restricted stock unit awards with 8,333 shares vesting on February 18, 2015 and 8,334 shares vesting on February 18, 2016, contingent upon Ms. Lin's continued service on such date. |
(32) | Restricted stock unit awards with 6,277 shares vesting on February 18, 2015 and 6,278 shares vesting on February 18, 2016, contingent upon Ms. Lin's continued service on such date. |
(33) | Restricted stock unit awards with 4,950 shares vesting on February 18, 2015, 4,950 shares vesting on February 18, 2016, and 5,100 shares vesting on February 18, 2017, contingent upon Ms. Lin's continued service on such date. |
(34) | Restricted stock units granted following Mr. Tarpey's retirement on August 28, 2014 in connection with appointment to the Company's advisory board. |
Name | Option Awards | Stock Awards | ||||
Number of Shares Acquired on Exercise (#) | Value Realized on Exercise ($)(1) | Number of Shares Acquired on Vesting (#) | Value Realized on Vesting ($) | |||
Serge Matta | — | — | 7,500 | 238,950(2) | ||
— | — | 1,858 | 59,196(2) | |||
— | — | 8,750 | 278,775(2) | |||
— | — | 16,666 | 531,312(3) | |||
— | — | 31,505(4) | 974,135(5) | |||
— | — | 2,268 | 70,127(5) | |||
— | — | 4,857 | 150,178(5) | |||
— | — | 5,000 | 195,950(6) | |||
Magid M. Abraham, Ph.D. | — | — | 8,694 | 276,991(2) | ||
— | — | 96,667 | 3,056,611(7) | |||
— | — | 65,250 | 2,063,205(7) | |||
— | — | 9,981 | 308,613(5) | |||
— | — | 70,000 | 2,307,900(8) | |||
— | — | 1,785(9) | 58,530(10) | |||
— | — | 1,649(9) | 58,507(11) | |||
— | — | 1,607(9) | 58,511(12) | |||
— | — | 1,260(9) | 58,502(13) | |||
Gian M. Fulgoni | — | — | 6,137 | 195,525(2) | ||
— | — | 8,333 | 265,489(2) | |||
— | — | 26,256(4) | 837,041(3) | |||
— | — | 6,695 | 207,009(5) | |||
— | — | 8,750 | 270,550(5) | |||
— | — | 3,460 | 106,983(5) | |||
— | — | 2,532(9) | 83,024(10) | |||
— | — | 2,340(9) | 83,023(11) | |||
— | — | 2,280(9) | 83,015(12) | |||
— | — | 1,788(9) | 83,017(13) | |||
Cameron Meierhoefer | — | — | 3,750 | 119,475(2) | ||
— | — | 1,839 | 58,591(2) | |||
— | — | 8,333 | 265,489(2) | |||
— | — | 13,261(4) | 422,761(3) | |||
— | — | 1,542 | 47,679(5) | |||
— | — | 8,750 | 270,550(5) | |||
— | — | 3,806 | 117,682(5) | |||
Christiana Lin | — | — | 500 | 15,930(2) | ||
— | — | 5,000 | 159,300(2) | |||
— | — | 2,231 | 71,080(2) | |||
— | — | 8,333 | 265,489(2) | |||
— | — | 12,775(4) | 407,267(3) | |||
— | — | 1,652 | 51,080(5) |
Name | Option Awards | Stock Awards | ||||
Number of Shares Acquired on Exercise (#) | Value Realized on Exercise ($)(1) | Number of Shares Acquired on Vesting (#) | Value Realized on Vesting ($) | |||
— | — | 6,250 | 193,250(5) | |||
— | — | 3,628 | 112,178(5) | |||
5000 | 173,400 | — | — | |||
5000 | 183,950 | — | — | |||
Kenneth J. Tarpey (retired August 28, 2014) | — | — | 5,000 | 159,300(2) | ||
— | — | 4,147 | 132,123(2) | |||
— | — | 8,333 | 265,489(2) | |||
— | — | 16,833(4) | 536,636(3) | |||
— | — | 2,381 | 73,621(5) | |||
— | — | 8,750 | 270,550(5) | |||
— | — | 1,262 | 39,021(5) | |||
— | — | 6,205 | 243,174(6) | |||
— | — | 2,381(14) | 93,311(6) | |||
— | — | 8,750(14) | 342,913(6) | |||
— | — | 1,262(14) | 49,458(6) | |||
— | — | 8,333(14) | 326,570(6) | |||
— | — | 6,277(14) | 245,996(6) |
(1) | The value realized on exercise is calculated as the difference between the actual sales price of the shares underlying the options exercised and the applicable exercise price of those options. |
(2) | The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $31.86 per share at market close as listed by the NASDAQ Global Market on February 18, 2014. |
(3) | The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $31.88 per share at market close as listed by the NASDAQ Global Market on February 19, 2014. |
(4) | Restricted stock units granted with immediate vesting. |
(5) | The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $30.92 per share at market close as listed by the NASDAQ Global Market on March 14, 2014. |
(6) | The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $39.19 per share at market close as listed by the NASDAQ Global Market on August 15, 2014. |
(7) | The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $31.62 per share at market close as listed by the NASDAQ Global Market on February 28, 2014. |
(8) | The value realized on vesting is calculated by multiplying the number of shares vesting by the market value of the underlying shares on the vesting date, which was $32.97 per share at market close as listed by the NASDAQ Global Market on March 29, 2014. |
(9) | Restricted stock units granted with immediate vesting awarded in lieu of cash salary. |
• | payment of all accrued but unpaid vacation, expense reimbursements, wages and other benefits due under our plans, policies and arrangements; |
• | continuing payments at a rate equal to his annual base salary then in effect, for the duration of a specified severance period (as identified in the table below for each such named executive officer), to be paid periodically in accordance with our normal payroll policies; and |
• | reimbursement of COBRA premiums (or an equivalent cash distribution if his severance period exceeds the permitted COBRA participation period) until the earlier of the expiration of the specified severance period or the date that he becomes covered under a similar plan. |
Name and Principal Position | Severance Period |
Serge Matta | 2 years |
Magid M. Abraham, Ph.D. | 2 years |
Gian M. Fulgoni | 1.5 years |
Melvin Wesley III | 6 months for first 2 years as CFO, then 1.25 years |
Cameron Meierhoefer | 1 year |
Christiana Lin | 1 year |
• | payment of all accrued but unpaid vacation, expense reimbursements, wages and other benefits due under our plans, policies and arrangements; |
• | a lump sum payment (less applicable withholding taxes) equal to a specified change in control multiple (as identified in the chart below for each such named executive officer) multiplied by his annual base salary in effect immediately prior to his termination date or, if greater, at the level in effect immediately prior to the change in control; and |
• | reimbursement of COBRA premiums (or an equivalent cash distribution if his severance period exceeds the permitted COBRA participation period) until the earlier of the expiration of a specified severance period (as identified in the table above for each such named executive officer) or the date that such he becomes covered under a similar plan. |
Name and Principal Position | Change of Control Multiple |
Serge Matta | 2x |
Magid M. Abraham, Ph.D. | 2x |
Gian M. Fulgoni | 1.5x |
Melvin Wesley III | 1.25x |
Cameron Meierhoefer | 1x |
Christiana Lin | 1x |
Name | Market Value of Accelerated Equity (net of exercise price, if any)(1) |
Serge Matta | —(2) |
Magid M. Abraham, Ph.D. | 10,445,868(3)(4) |
Gian M. Fulgoni | 3,126,643(3) |
Melvin Wesley III | —(2) |
Cameron Meierhoefer | —(2) |
Christiana Lin | —(2) |
(1) | Based on an assumed fair market value per share of our common stock of $46.43, which was the closing price of our common stock as reported by the NASDAQ Global Market on December 31, 2014. |
(2) | Each of the agreements with Messrs. Wesley, Matta and Meierhoefer and Ms. Lin provides that if each such named executive officer remains employed by or continues to provide services to us through the one-year anniversary of a change of control of the Company , all of such named executive officer’s outstanding and unvested equity awards as of the date of such change of control would then become vested in full. |
(3) | Dr. Abraham and Mr. Fulgoni are parties to Severance and Change of Control Agreements whereby each named executive officer’s outstanding and unvested equity awards become vested in full upon a change of control of the Company. |
(4) | The referenced amount includes the acceleration of 145,000 unvested performance-based restricted stock and restricted stock units held by Dr. Abraham as of December 31, 2014. Of such amount, 28,352 restricted stock units related to overachievement of pre-established targets were subsequently canceled in 2015 as the components of 2014 performance awards did not satisfy the vesting criteria required to earn such shares. Excluding these shares, the market value of accelerating the outstanding and unvested equity awards of Dr. Abraham as of December 31, 2014 would have been $9,129,484. |
Cash Payments | Market Value of Accelerated Equity (net of exercise price, if any)(3) | ||||||||
Name | Salary(1) | COBRA/ Insurance(2) | |||||||
Serge Matta | $ | 950,000 | $ | 42,804 | $ | — | |||
Magid M. Abraham, Ph.D. | 500,000 | 42,804 | 10,445,868(4)(5) | ||||||
Gian M. Fulgoni | 562,500 | 21,012 | 3,126,643(4) | ||||||
Melvin Wesley III | 160,000 | 6,555 | — | ||||||
Cameron Meierhoefer | 353,000 | 21,402 | — | ||||||
Christiana Lin | 333,000 | 21,139 | — |
(1) | Salary to be paid at a rate equal to such named executive officer’s annual base salary then in effect, for the duration of a specified severance period, to be paid periodically in accordance with our normal payroll policies. |
(2) | COBRA/Insurance payments are estimated based on the number of months of coverage for which we are contractually obligated and the current estimated premium costs. |
(3) | Based on an assumed fair market value per share of our common stock of $46.43, which was the closing price of our common stock as reported by the NASDAQ Global Market on December 31, 2014. |
(4) | Dr. Abraham and Mr. Fulgoni are parties to Severance and Change of Control Agreements whereby each named executive officer’s outstanding and unvested equity awards become vested in full upon a termination of employment without cause or by the named executive officer for good reason. |
Cash Payments | Market Value of Accelerated Equity(net of exercise price, if any)(3) | ||||||
Name | Salary(1) | COBRA/ Insurance(2) | |||||
Serge Matta | $ | 950,000 | $ | 42,804 | 6,269,396(4)(5) | ||
Magid M. Abraham, Ph.D. | 500,000 | 42,804 | 10,445,868(6)(7) | ||||
Gian M. Fulgoni | 562,500 | 21,012 | 3,126,643(6) | ||||
Melvin Wesley III | 400,000 | 16,387 | 464,300(4) | ||||
Cameron Meierhoefer | 353,000 | 21,402 | 3,114,107(4) | ||||
Christiana Lin | 333,000 | 21,139 | 2,878,753(4) |
(1) | Gross amount of lump sum payment (prior to payment of applicable withhold taxes). |
(2) | COBRA/Insurance payments are estimated based on the number of months of coverage for which we are contractually obligated and the current estimated premium costs. |
(3) | Based on an assumed fair market value per share of our common stock of $46.43, which was the closing price of our common stock as reported by the NASDAQ Global Market on December 31, 2014. |
(4) | Each of the agreements with Messrs. Matta, Wesley and Meierhoefer and Ms. Lin provides that if each such named executive officer remains employed by or continues to provide services to us through the one-year anniversary of a change in control of comScore, all of such named executive officer’s outstanding and unvested equity awards become vested in full. |
(6) | Dr. Abraham and Mr. Fulgoni are parties to Severance and Change of Control Agreements whereby each named executive officer’s outstanding and unvested equity awards become vested in full upon a change in control of comScore. |
(7) | The referenced amount includes the acceleration of 145,000 unvested performance-based restricted stock and restricted stock units held by Dr. Abraham as of December 31, 2014. Of such amount, 28,352 restricted stock units related to overachievement of pre-established targets were subsequently canceled in 2015 as the components of 2014 performance awards did not satisfy the vesting criteria required to earn such shares. Excluding these shares, the market value of accelerating the outstanding and unvested equity awards of Dr. Abraham as of December 31, 2014 would have been $9,129,484. |
• | each beneficial owner of 5% or more of the outstanding shares of our common stock; |
• | each of our directors; |
• | each of our named executive officers; and |
• | all of our executive officers and directors as a group. |
Name and Address of Beneficial Owner | Amount and Nature of Beneficial Ownership(1) | Percentage of Common Stock Outstanding | ||
5% or Greater Stockholders: | ||||
WPP plc and affiliated entities(2) | 6,076,978 | 15.0 | % | |
PRIMECAP Management Company(3) | 4,150,532 | 12.1 | % | |
Blackrock, Inc.(4) | 3,426,390 | 10.0 | % | |
The Vanguard Group(5) | 2,303,291 | 6.7 | % | |
Directors and Named Executive Officers: | ||||
Serge Matta(6) | 820,534 | 2.0 | % | |
Magid M. Abraham, Ph.D.(7) | 166,986 | * | ||
Gian M. Fulgoni(8) | 167,790 | * | ||
Melvin Wesley III(9) | 168,033 | * | ||
Cameron Meierhoefer(10) | 222,504 | * | ||
Christiana Lin(11) | 239,467 | * | ||
Russell Fradin | — | * | ||
William J. Henderson | 24,925 | * | ||
William Katz | 25,517 | * | ||
Ronald J. Korn | 37,748 | * | ||
Joan M. Lewis | — | * | ||
All directors and executive officers as a group (twelve persons)(12) | 1,982,558 | 4.9 | % |
* | Represents less than 1% of the outstanding shares of common stock. |
(1) | The information provided in this table is based on our records, information supplied to us by our executive officers, directors and principal stockholders and information contained in Schedules 13D and 13G filed with the SEC. |
(2) | This information is derived solely from the Schedule 13D filed with the SEC on April 7, 2015. Each of WPP plc and Cavendish Square Holding B.V. a subsidiary of WPP plc, have shared voting power and shared dispositive power of 6,076,978 shares. The address for WPP plc is 27 Farm Street, London, united Kingdom W1J 5RJ. The address for Cavendish Square Holding B.V. is Laan op Zuid 167, 3072 DB Rotterdam, Netherlands. |
(3) | This information is derived solely from the Schedule 13G/A filed with the SEC on February 13, 2015. PRIMECAP Management Company has sole voting power of 3,470,360 shares and sole dispositive power of 4,150,532 shares. The address for PRIMECAP Management Company is 225 south Lake Ave., #400, Pasadena, CA 91101. . |
(4) | This information is derived solely from the Schedule 13G/A filed with the SEC on February 10, 2015. Blackrock, Inc. has sole voting power of 3,351,333 shares and sole dispositive power of 3,426,390 shares. The address for Blackrock, Inc. is 55 East 52nd Street, New York, NY 10022. |
(5) | This information is derived solely from the Schedule 13G/A filed with the SEC on February 11, 2015. The Vanguard Group has sole voting power of 46,879 shares, sole dispositive power of 2,259,712, and shared dispositive power of 43,579 shares. The address for the Vanguard Group is 100 Vanguard Blvd., Malvern, PA 19355. |
(6) | Includes 743,468 shares subject to options that are immediately exercisable or exercisable within 60 days of April 1, 2015. Additionally, includes 8,750 shares subject to a right of repurchase held by us pursuant to a restricted stock agreement. |
(7) | Includes 33,947 shares held indirectly by spouse of which 6,250 shares are subject to a right of repurchase held by us pursuant to a restricted stock agreement. |
(8) | Includes 8,750 shares subject to a right of repurchase held by us pursuant to a restricted stock agreement. |
(9) | Includes 166,309 shares subject to options that are immediately exercisable or exercisable within 60 days of April 1, 2015. |
Date Filed | Form | Name(s) of Filer(s) | Description |
February 21, 2014 | 4 | Magid Abraham | Filing related to transaction originally occurring on February 14, 2014. |
March 5, 2014 | 4 | Magid Abraham | Filing related to transaction originally occurring on February 28, 2014. |
March 19, 2014 and April 1, 2014 | 4 | Magid Abraham Serge Matta Gian Fulgoni Christiana Lin Kenneth Tarpey Cameron Meierhoefer | Filing related to transaction originally occurring on March 14, 2014. |
April 14, 2014 | 4 | Magid Abraham Cameron Meierhoefer | Filing related to transaction originally occurring on April 9, 2014. |
April 30, 2014 | 4 | Christiana Lin Cameron Meierhoefer | Filing related to transaction originally occurring on April 27, 2014. |
August 5, 2014 | 4 | Cameron Meierhoefer | Filing related to transaction originally occurring on July 30, 2014. |
August 22, 2014 | 4/A | Kenneth Tarpey | Amended Form 4 related to transaction originally occurring on August 15, 2014. |